Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Microsoft could grab TikTok 'for a song,' Barron's says » 10:03
08/08/20
08/08
10:03
08/08/20
10:03
AAPL

Apple

$444.41 /

-10.98 (-2.41%)

, AMZN

Amazon.com

$3,167.40 /

-54.81 (-1.70%)

, GOOGL

Alphabet Class A

$1,497.80 /

-6.1 (-0.41%)

, GOOG

Alphabet

$1,495.37 /

-6.16 (-0.41%)

, MSFT

Microsoft

$212.45 /

-3.87 (-1.79%)

, FB

Facebook

$268.52 /

+3.295 (+1.24%)

Near the start of the…

Near the start of the pandemic, TikTok became the most download app in a single quarter and it's the first social media platform in the past decade to have a shot at rivaling Facebook (FB) and its Instagram platform in users, if not profits, Jack Hough writes in this week's edition of Barron's. That makes it all the more surprising that Microsoft (MSFT) might walk away with TikTok "for a song," the author adds. Facebook and Google parent Alphabet (GOOGL) would love to bid, but they're in the regulatory naughty corner, fresh off an antitrust hearing in Congress, along with Amazon.com (AMZN) and Apple (AAPL), the publication notes. Reference Link

ShowHide Related Items >><<
MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

GOOGL Alphabet Class A
$1,497.80 /

-6.1 (-0.41%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

08/06/20 KeyBanc
Synaptics upgraded to Overweight from Sector Weight at KeyBanc
08/06/20 Barclays
SiTime price target raised to $75 from $50 at Barclays
08/05/20
Fly Intel: Top five analyst downgrades
08/05/20 Wells Fargo
Apple price target raised to $485 from $450 at Wells Fargo
AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

08/07/20 DA Davidson
Datadog price target raised to $80 from $52 at DA Davidson
08/03/20 Morgan Stanley
ADT Inc. price target raised to $17 from $7 at Morgan Stanley
07/31/20 BMO Capital
Amazon.com price target raised to $3,700 from $3,500 at BMO Capital
07/31/20 RBC Capital
Amazon.com price target raised to $3,800 from $3,300 at RBC Capital
GOOGL Alphabet Class A
$1,497.80 /

-6.1 (-0.41%)

08/03/20 Goldman Sachs
ADT Inc. price target raised to $17 from $9 at Goldman Sachs
08/03/20 William Blair
Alarm.com downgraded at William Blair on ADT/Google overhang
08/03/20 William Blair
Alarm.com downgraded to Market Perform from Outperform at William Blair
GOOG Alphabet
$1,495.37 /

-6.16 (-0.41%)

08/03/20 Credit Suisse
ADT Inc. price target raised to $8.70 from $7 at Credit Suisse
MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

08/05/20 Morgan Stanley
Morgan Stanley says TikTok US operations could be 'compelling' fit for Microsoft
08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
FB Facebook
$268.52 /

+3.295 (+1.24%)

08/05/20 HSBC
HSBC bumps up Facebook target to $195, maintains Reduce rating
08/04/20 Argus
Facebook price target raised to $300 from $270 at Argus
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

GOOGL Alphabet Class A
$1,497.80 /

-6.1 (-0.41%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

GOOGL Alphabet Class A
$1,497.80 /

-6.1 (-0.41%)

GOOG Alphabet
$1,495.37 /

-6.16 (-0.41%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

GOOGL Alphabet Class A
$1,497.80 /

-6.1 (-0.41%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

AAPL Apple
$444.41 /

-10.98 (-2.41%)

On The Fly
Week in review: How Trump's policies moved stocks » 07:32
08/08/20
08/08
07:32
08/08/20
07:32
TCEHY

Tencent

$0.00 /

+ (+0.00%)

, MSFT

Microsoft

$212.45 /

-3.87 (-1.79%)

, AZN

AstraZeneca

$55.40 /

-0.8 (-1.42%)

, BMY

Bristol-Myers

$61.03 /

-0.27 (-0.44%)

, LLY

Eli Lilly

$152.89 /

+0.01 (+0.01%)

, GSK

GlaxoSmithKline

$40.79 /

-0.185 (-0.45%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, KODK

Eastman Kodak

$14.88 /

-1.195 (-7.43%)

, AA

Alcoa

$14.67 /

-0.22 (-1.48%)

, CENX

Century Aluminum

$10.53 /

-0.06 (-0.57%)

, KALU

Kaiser Aluminum

$66.81 /

+0.49 (+0.74%)

, ARNC

Arconic

$19.94 /

-0.395 (-1.94%)

, FB

Facebook

$268.52 /

+3.295 (+1.24%)

, TWTR

Twitter

$37.14 /

-0.55 (-1.46%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
TWTR Twitter
$37.14 /

-0.55 (-1.46%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

KODK Eastman Kodak
$14.88 /

-1.195 (-7.43%)

KALU Kaiser Aluminum
$66.81 /

+0.49 (+0.74%)

GSK GlaxoSmithKline
$40.79 /

-0.185 (-0.45%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

CENX Century Aluminum
$10.53 /

-0.06 (-0.57%)

BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

AZN AstraZeneca
$55.40 /

-0.8 (-1.42%)

ARNC Arconic
$19.94 /

-0.395 (-1.94%)

AA Alcoa
$14.67 /

-0.22 (-1.48%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

08/03/20 Morgan Stanley
Sohu.com named a Research Tactical Idea at Morgan Stanley
07/27/20 Barclays
Tencent price target raised to $75 from $63 at Barclays
07/14/20 Citi
Tencent price target raised to HK$649 from HK$541 at Citi
07/08/20 Mizuho
Tencent price target raised to HK$475 from HK$410 at Mizuho
MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

08/07/20 DA Davidson
Datadog price target raised to $80 from $52 at DA Davidson
08/05/20 Morgan Stanley
Morgan Stanley says TikTok US operations could be 'compelling' fit for Microsoft
08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
AZN AstraZeneca
$55.40 /

-0.8 (-1.42%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Raymond James
Bristol-Myers initiated with an Outperform at Raymond James
LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

07/31/20 Barclays
Eli Lilly earnings selloff 'meaningful over-reaction,' says Barclays
07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
GSK GlaxoSmithKline
$40.79 /

-0.185 (-0.45%)

07/31/20 Barclays
Barclays backs Underweight on GSK after 'challenging' Q2
07/30/20 Roth Capital
Roth Capital bullish on Ideaya as GSK highlights synthetic lethality pipeline
07/13/20 UBS
UBS reiterates Buy on GSK as FDA belantamab docs are out
07/13/20 JPMorgan
Ideaya upgraded to Overweight on recent pullback at JPMorgan
RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
KODK Eastman Kodak
$14.88 /

-1.195 (-7.43%)

AA Alcoa
$14.67 /

-0.22 (-1.48%)

07/16/20 B. Riley FBR
Alcoa price target raised to $11 from $9 at B. Riley FBR
06/16/20
Fly Intel: Top five analyst downgrades
06/16/20 Deutsche Bank
Alcoa downgraded to Hold with $10 price target at Deutsche Bank
06/15/20 Deutsche Bank
Alcoa downgraded to Hold from Buy at Deutsche Bank
CENX Century Aluminum
$10.53 /

-0.06 (-0.57%)

06/25/20 BMO Capital
Century Aluminum downgraded to Market Perform from Outperform at BMO Capital
06/09/20 B. Riley FBR
B. Riley FBR downgrades Contura Energy after liquidity stress test
03/24/20 B. Riley FBR
Century Aluminum downgraded to Neutral from Buy at B. Riley FBR
12/20/19 B. Riley FBR
Alcoa price target lowered to $25 from $28 at B. Riley FBR
KALU Kaiser Aluminum
$66.81 /

+0.49 (+0.74%)

01/16/20 Benchmark
Kaiser Aluminum initiated with a Hold at Benchmark
08/08/19 Goldman Sachs
Kaiser Aluminum upgraded to Neutral from Sell at Goldman Sachs
ARNC Arconic
$19.94 /

-0.395 (-1.94%)

05/20/20
Fly Intel: Top five analyst initiations
05/20/20 Credit Suisse
Arconic initiated with an Outperform at Credit Suisse
04/01/20 Cowen
Howmet Aerospace price target lowered to $17 from $23 at Cowen
03/20/20 Barclays
Arconic downgraded to Equal Weight from Overweight at Barclays
FB Facebook
$268.52 /

+3.295 (+1.24%)

08/05/20 HSBC
HSBC bumps up Facebook target to $195, maintains Reduce rating
08/04/20 Argus
Facebook price target raised to $300 from $270 at Argus
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
TWTR Twitter
$37.14 /

-0.55 (-1.46%)

07/28/20 Morgan Stanley
Morgan Stanley lowers near-term, long-term forecasts for Roku
07/24/20 Truist
Twitter price target raised to $40 from $32 at SunTrust
07/24/20 Argus
Twitter price target raised to $46 from $40 at Argus
07/24/20 Canaccord
Twitter price target raised to $40 from $32 at Canaccord
TWTR Twitter
$37.14 /

-0.55 (-1.46%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

KALU Kaiser Aluminum
$66.81 /

+0.49 (+0.74%)

GSK GlaxoSmithKline
$40.79 /

-0.185 (-0.45%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

CENX Century Aluminum
$10.53 /

-0.06 (-0.57%)

BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

AZN AstraZeneca
$55.40 /

-0.8 (-1.42%)

ARNC Arconic
$19.94 /

-0.395 (-1.94%)

AA Alcoa
$14.67 /

-0.22 (-1.48%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

KODK Eastman Kodak
$14.88 /

-1.195 (-7.43%)

GSK GlaxoSmithKline
$40.79 /

-0.185 (-0.45%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

AZN AstraZeneca
$55.40 /

-0.8 (-1.42%)

AA Alcoa
$14.67 /

-0.22 (-1.48%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

GSK GlaxoSmithKline
$40.79 /

-0.185 (-0.45%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

AZN AstraZeneca
$55.40 /

-0.8 (-1.42%)

ARNC Arconic
$19.94 /

-0.395 (-1.94%)

AA Alcoa
$14.67 /

-0.22 (-1.48%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

KODK Eastman Kodak
$14.88 /

-1.195 (-7.43%)

GSK GlaxoSmithKline
$40.79 /

-0.185 (-0.45%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

AZN AstraZeneca
$55.40 /

-0.8 (-1.42%)

ARNC Arconic
$19.94 /

-0.395 (-1.94%)

AA Alcoa
$14.67 /

-0.22 (-1.48%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

Yesterday
Syndicate
Gilead files automatic mixed securities shelf  16:04
08/07/20
08/07
16:04
08/07/20
16:04
GILD

Gilead

$69.31 /

+0.51 (+0.74%)

 
ShowHide Related Items >><<
GILD Gilead
$69.31 /

+0.51 (+0.74%)

GILD Gilead
$69.31 /

+0.51 (+0.74%)

08/03/20 Citi
Gilead price target raised to $80 from $78 at Citi
07/31/20 Wells Fargo
Gilead price target lowered to $76 from $87 at Wells Fargo
07/30/20 Piper Sandler
Gilead price target lowered to $85 from $90 at Piper Sandler
07/28/20 Piper Sandler
Piper Sandler lowers FY20, FY21 earnings forecasts for Gilead
GILD Gilead
$69.31 /

+0.51 (+0.74%)

GILD Gilead
$69.31 /

+0.51 (+0.74%)

GILD Gilead
$69.31 /

+0.51 (+0.74%)

GILD Gilead
$69.31 /

+0.51 (+0.74%)

Periodicals
Facebook condemns Apple's App Store policies, Verge reports » 11:12
08/07/20
08/07
11:12
08/07/20
11:12
FB

Facebook

$278.37 /

+13.145 (+4.96%)

, AAPL

Apple

$452.65 /

-2.74 (-0.60%)

, MSFT

Microsoft

$215.04 /

-1.28 (-0.59%)

Facebook (FB) has…

Facebook (FB) has condemned Apple's (AAPL) App Store policies, The Verge's Tom Warren reports. The social media giant, which joined Microsoft (MSFT) in criticizing the iPhone maker, is rolling out its Facebook Gaming app for iOS, but has had to remove the app's mini games feature to pass Apple's strict App Store approval process, Warren says. "Unfortunately, we had to remove gameplay functionality entirely in order to get Apple's approval on the standalone Facebook Gaming app - meaning iOS users have an inferior experience to those using Android," Facebook COO Sheryl Sandberg said in a press statement given to The Verge. "We're staying focused on building communities for the more than 380 million people who play games on Facebook every month - whether Apple allows it in a standalone app or not." Reference Link

ShowHide Related Items >><<
MSFT Microsoft
$215.04 /

-1.28 (-0.59%)

FB Facebook
$278.37 /

+13.145 (+4.96%)

AAPL Apple
$452.65 /

-2.74 (-0.60%)

FB Facebook
$278.37 /

+13.145 (+4.96%)

08/05/20 HSBC
HSBC bumps up Facebook target to $195, maintains Reduce rating
08/04/20 Argus
Facebook price target raised to $300 from $270 at Argus
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
AAPL Apple
$452.65 /

-2.74 (-0.60%)

08/06/20 KeyBanc
Synaptics upgraded to Overweight from Sector Weight at KeyBanc
08/06/20 Barclays
SiTime price target raised to $75 from $50 at Barclays
08/05/20
Fly Intel: Top five analyst downgrades
08/05/20 Wells Fargo
Apple price target raised to $485 from $450 at Wells Fargo
MSFT Microsoft
$215.04 /

-1.28 (-0.59%)

08/07/20 DA Davidson
Datadog price target raised to $80 from $52 at DA Davidson
08/05/20 Morgan Stanley
Morgan Stanley says TikTok US operations could be 'compelling' fit for Microsoft
08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
MSFT Microsoft
$215.04 /

-1.28 (-0.59%)

FB Facebook
$278.37 /

+13.145 (+4.96%)

AAPL Apple
$452.65 /

-2.74 (-0.60%)

MSFT Microsoft
$215.04 /

-1.28 (-0.59%)

FB Facebook
$278.37 /

+13.145 (+4.96%)

AAPL Apple
$452.65 /

-2.74 (-0.60%)

MSFT Microsoft
$215.04 /

-1.28 (-0.59%)

FB Facebook
$278.37 /

+13.145 (+4.96%)

AAPL Apple
$452.65 /

-2.74 (-0.60%)

MSFT Microsoft
$215.04 /

-1.28 (-0.59%)

FB Facebook
$278.37 /

+13.145 (+4.96%)

AAPL Apple
$452.65 /

-2.74 (-0.60%)

AAPL Apple
$452.65 /

-2.74 (-0.60%)

Options
Overstock com call volume above normal and directionally bullish » 10:45
08/07/20
08/07
10:45
08/07/20
10:45
OSTK

Overstock.com

$102.70 /

+8.59 (+9.13%)

Bullish option flow…

Bullish option flow detected in Overstock com with 13,088 calls trading, 4x expected, and implied vol increasing almost 2 points to 131.35%. 8/7 weekly 100 calls and 8/7 weekly 105 calls are the most active options, with total volume in those strikes near 4,700 contracts. The Put/Call Ratio is 0.25. Earnings are expected on November 9th.

ShowHide Related Items >><<
OSTK Overstock.com
$102.70 /

+8.59 (+9.13%)

OSTK Overstock.com
$102.70 /

+8.59 (+9.13%)

07/31/20 DA Davidson
Overstock.com price target raised to $103 from $66 at DA Davidson
07/02/20 DA Davidson
Overstock.com price target raised to $66 from $33 at DA Davidson
05/12/20 Jefferies
Overstock.com 130% sales jump positive for Wayfair, says Jefferies
05/06/20 DA Davidson
Wayfair price target raised to $100 from $45 at DA Davidson
OSTK Overstock.com
$102.70 /

+8.59 (+9.13%)

OSTK Overstock.com
$102.70 /

+8.59 (+9.13%)

OSTK Overstock.com
$102.70 /

+8.59 (+9.13%)

On The Fly
The Intersection: Crypto and Wall Street This Week » 09:44
08/07/20
08/07
09:44
08/07/20
09:44
BTC

Bitcoin

$0.00 /

+ (+0.00%)

, BITCOIN

Bitcoin

$0.00 /

+ (+0.00%)

, TWTR

Twitter

$37.69 /

+ (+0.00%)

, GS

Goldman Sachs

$204.29 /

+ (+0.00%)

, AMD

AMD

$86.70 /

+ (+0.00%)

, NVDA

Nvidia

$453.42 /

+ (+0.00%)

, OSTK

Overstock.com

$94.11 /

+ (+0.00%)

, IDEX

Ideanomics

$1.65 /

+ (+0.00%)

, RIOT

Riot Blockchain

$4.22 /

+ (+0.00%)

, TEUM

Pareteum

$0.79 /

+ (+0.00%)

, SRAX

Srax

$2.85 /

+ (+0.00%)

As bitcoin, ethereum and…

Open Full Text

ShowHide Related Items >><<
TWTR Twitter
$37.69 /

+ (+0.00%)

TEUM Pareteum
$0.79 /

+ (+0.00%)

RIOT Riot Blockchain
$4.22 /

+ (+0.00%)

OSTK Overstock.com
$94.11 /

+ (+0.00%)

NVDA Nvidia
$453.42 /

+ (+0.00%)

IDEX Ideanomics
$1.65 /

+ (+0.00%)

GS Goldman Sachs
$204.29 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

AMD AMD
$86.70 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

01/23/20 Morgan Stanley
PayPal acceptance gap widens against Amazon, Bitcoin, says Morgan Stanley
BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

TWTR Twitter
$37.69 /

+ (+0.00%)

07/28/20 Morgan Stanley
Morgan Stanley lowers near-term, long-term forecasts for Roku
07/24/20 Truist
Twitter price target raised to $40 from $32 at SunTrust
07/24/20 Argus
Twitter price target raised to $46 from $40 at Argus
07/24/20 Canaccord
Twitter price target raised to $40 from $32 at Canaccord
GS Goldman Sachs
$204.29 /

+ (+0.00%)

08/06/20 Piper Sandler
Now is the time to buy Goldman Sachs, says Piper Sandler
07/20/20 Berenberg
Goldman Sachs price target raised to $200 from $160 at Berenberg
07/16/20 DA Davidson
Goldman Sachs price target raised to $238 from $215 at DA Davidson
07/16/20 Oppenheimer
Goldman Sachs price target raised to $355 from $335 at Oppenheimer
AMD AMD
$86.70 /

+ (+0.00%)

08/04/20 Jefferies
AMD price target raised to $95 from $86 at Jefferies
07/29/20
Fly Intel: Top five analyst downgrades
07/29/20
Fly Intel: Top five analyst upgrades
07/29/20 JPMorgan
AMD price target raised to $62 from $52 at JPMorgan
NVDA Nvidia
$453.42 /

+ (+0.00%)

08/03/20 Morgan Stanley
Synergies unclear if Nvidia buys controlling ARM interest, says Morgan Stanley
07/24/20 Raymond James
Intel 7nm delay positive for AMD, TSMC, Nvidia, says Raymond James
07/24/20 BMO Capital
Intel price target lowered to $50 from $55 at BMO Capital
07/14/20 Cowen
Nvidia price target raised to $475 from $410 at Cowen
OSTK Overstock.com
$94.11 /

+ (+0.00%)

07/31/20 DA Davidson
Overstock.com price target raised to $103 from $66 at DA Davidson
07/02/20 DA Davidson
Overstock.com price target raised to $66 from $33 at DA Davidson
05/12/20 Jefferies
Overstock.com 130% sales jump positive for Wayfair, says Jefferies
05/06/20 DA Davidson
Wayfair price target raised to $100 from $45 at DA Davidson
IDEX Ideanomics
$1.65 /

+ (+0.00%)

RIOT Riot Blockchain
$4.22 /

+ (+0.00%)

TEUM Pareteum
$0.79 /

+ (+0.00%)

10/22/19 Lake Street
Pareteum downgraded to Hold from Buy at Lake Street
10/22/19 Northland
Northland cuts Pareteum to Market Perform after 'unusually large' restatement
10/22/19 Oppenheimer
Pareteum downgraded to Perform at Oppenheimer
10/22/19 Oppenheimer
Pareteum downgraded to Perform from Outperform at Oppenheimer
SRAX Srax
$2.85 /

+ (+0.00%)

07/06/20
Fly Intel: Top five analyst initiations
07/06/20 B. Riley FBR
B. Riley FBR starts Srax at Buy on 'rapid adoption' of Sequire
07/06/20 B. Riley FBR
Srax initiated with a Buy at B. Riley FBR
TWTR Twitter
$37.69 /

+ (+0.00%)

OSTK Overstock.com
$94.11 /

+ (+0.00%)

NVDA Nvidia
$453.42 /

+ (+0.00%)

GS Goldman Sachs
$204.29 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

AMD AMD
$86.70 /

+ (+0.00%)

TWTR Twitter
$37.69 /

+ (+0.00%)

NVDA Nvidia
$453.42 /

+ (+0.00%)

IDEX Ideanomics
$1.65 /

+ (+0.00%)

GS Goldman Sachs
$204.29 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

AMD AMD
$86.70 /

+ (+0.00%)

TWTR Twitter
$37.69 /

+ (+0.00%)

OSTK Overstock.com
$94.11 /

+ (+0.00%)

NVDA Nvidia
$453.42 /

+ (+0.00%)

GS Goldman Sachs
$204.29 /

+ (+0.00%)

BTC Bitcoin
$0.00 /

+ (+0.00%)

BITCOIN Bitcoin
$0.00 /

+ (+0.00%)

AMD AMD
$86.70 /

+ (+0.00%)

TWTR Twitter
$37.69 /

+ (+0.00%)

TEUM Pareteum
$0.79 /

+ (+0.00%)

RIOT Riot Blockchain
$4.22 /

+ (+0.00%)

OSTK Overstock.com
$94.11 /

+ (+0.00%)

NVDA Nvidia
$453.42 /

+ (+0.00%)

IDEX Ideanomics
$1.65 /

+ (+0.00%)

GS Goldman Sachs
$204.29 /

+ (+0.00%)

AMD AMD
$86.70 /

+ (+0.00%)

Hot Stocks
Biohaven Pharmaceutical, Royalty Pharma announce funding agreement » 09:42
08/07/20
08/07
09:42
08/07/20
09:42
BHVN

Biohaven Pharmaceutical

$63.43 /

+ (+0.00%)

, RPRX

Royalty Pharma

$43.91 /

+ (+0.00%)

Biohaven Pharmaceutical…

Biohaven Pharmaceutical (BHVN) and Royalty Pharma (RPRX) announced that Biohaven has secured up to $250M in funding to advance the company's CGRP receptor antagonist program through the development of zavegepant. The zavegepant program encompasses intranasal zavegepant as well as oral zavegepant for migraine prevention and non-migraine indications. In exchange for these funds, Royalty Pharma will obtain a 0.4% royalty on annual worldwide net sales of Nurtec ODT and if certain zavegepant regulatory approvals are achieved, a royalty of up to 3% on annual worldwide net sales of zavegepant and success-based milestone payments. The success-based milestone payments range from 0.6x to 2.95x of the zavegepant funded amount depending on the number of regulatory approvals achieved for zavegepant (including 1.9x for the first zavegepant migraine regulatory approval) and would be paid over a ten-year period. Biohaven will receive $150M at closing and $100M upon the start of the oral zavegepant Phase 3 program. Royalty Pharma will also provide further support for the ongoing launch of Nurtec ODT through the committed, non-contingent purchase of Commercial Launch Preferred Equity from Biohaven for a total of $200M payable between 2021 and 2024. In return, Biohaven will pay to Royalty Pharma a series of equal fixed payments between 2025 and 2030 with an internal rate of return of approximately 12%.

ShowHide Related Items >><<
RPRX Royalty Pharma
$43.91 /

+ (+0.00%)

BHVN Biohaven Pharmaceutical
$63.43 /

+ (+0.00%)

BHVN Biohaven Pharmaceutical
$63.43 /

+ (+0.00%)

07/29/20 Piper Sandler
Piper says AbbVie's atogepant 'may yet emerge as best in class'
07/29/20 Piper Sandler
Biohaven migraine competitor shows constipation signal, says Piper Sandler
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/25/20 Mizuho
Biohaven selloff yesterday a buying opportunity, says Mizuho
RPRX Royalty Pharma
$43.91 /

+ (+0.00%)

07/20/20 Truist
PTC Therapeutics price target raised to $86 from $75 at SunTrust
07/13/20 Cowen
Cowen starts Royalty Pharma with Outperform, $55 price target
07/13/20 JPMorgan
Royalty Pharma initiated with a Neutral at JPMorgan
07/13/20 Morgan Stanley
Morgan Stanley starts Royalty Pharma at Equal Weight with $51 price target
BHVN Biohaven Pharmaceutical
$63.43 /

+ (+0.00%)

  • 16
    Jun
  • 29
    Jan
BHVN Biohaven Pharmaceutical
$63.43 /

+ (+0.00%)

RPRX Royalty Pharma
$43.91 /

+ (+0.00%)

BHVN Biohaven Pharmaceutical
$63.43 /

+ (+0.00%)

RPRX Royalty Pharma
$43.91 /

+ (+0.00%)

BHVN Biohaven Pharmaceutical
$63.43 /

+ (+0.00%)

Options
Notable open interest changes for August 7th » 08:55
08/07/20
08/07
08:55
08/07/20
08:55
WFC

Wells Fargo

$24.25 /

+0.07 (+0.29%)

, FB

Facebook

$265.23 /

+16.045 (+6.44%)

, AAL

American Airlines

$13.04 /

+0.48 (+3.82%)

, UBER

Uber

$34.70 /

+1.49 (+4.49%)

Thursday's total…

Thursday's total option volume of 30.7 million contracts resulted in net open interest growth of 3.42 million calls and 3.01 million puts. Wells Fargo (WFC), Facebook (FB), American Airlines (AAL) and Uber (UBER) saw the greatest growth. Top five new positions opened include 91k Wells Fargo (WFC) Sep-20 25 calls, 91k Wells Fargo (WFC) Sep-20 25 puts, 41k General Electric (GE) 8/14 weekly 6 puts, 33k Wells Fargo (WFC) 9/11 weekly 23.5 puts and 33k Wells Fargo (WFC) 9/11 weekly 24.5 calls.

ShowHide Related Items >><<
WFC Wells Fargo
$24.25 /

+0.07 (+0.29%)

UBER Uber
$34.70 /

+1.49 (+4.49%)

FB Facebook
$265.23 /

+16.045 (+6.44%)

AAL American Airlines
$13.04 /

+0.48 (+3.82%)

WFC Wells Fargo
$24.25 /

+0.07 (+0.29%)

07/22/20 Atlantic Equities
Atlantic upgrades Wells Fargo to Neutral post dividend cut
07/22/20 Atlantic Equities
Wells Fargo upgraded to Neutral from Underweight at Atlantic Equities
07/16/20 BMO Capital
Wells Fargo price target lowered to $36 from $41 at BMO Capital
07/15/20
Fly Intel: Top five analyst upgrades
FB Facebook
$265.23 /

+16.045 (+6.44%)

08/05/20 HSBC
HSBC bumps up Facebook target to $195, maintains Reduce rating
08/04/20 Argus
Facebook price target raised to $300 from $270 at Argus
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
AAL American Airlines
$13.04 /

+0.48 (+3.82%)

07/28/20 Citi
Citi cuts American Airlines target to $11, opens negative catalyst watch
07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Raymond James
American Airlines upgraded at Raymond James on balanced risk-reward
07/27/20 Raymond James
American Airlines upgraded to Market Perform from Underperform at Raymond James
UBER Uber
$34.70 /

+1.49 (+4.49%)

08/07/20 Morgan Stanley
Uber price target raised to $46 from $44 at Morgan Stanley
08/07/20 Wedbush
Uber price target lowered to $41 from $47 at Wedbush
08/07/20 Mizuho
Uber price target raised to $42 from $40 at Mizuho
08/07/20 KeyBanc
Uber's results likely to remain 'inconsistent' in the near-term, says KeyBanc
WFC Wells Fargo
$24.25 /

+0.07 (+0.29%)

UBER Uber
$34.70 /

+1.49 (+4.49%)

FB Facebook
$265.23 /

+16.045 (+6.44%)

AAL American Airlines
$13.04 /

+0.48 (+3.82%)

  • 23
    Jun
  • 11
    Feb
  • 07
    Nov
  • 06
    Nov
WFC Wells Fargo
$24.25 /

+0.07 (+0.29%)

UBER Uber
$34.70 /

+1.49 (+4.49%)

FB Facebook
$265.23 /

+16.045 (+6.44%)

AAL American Airlines
$13.04 /

+0.48 (+3.82%)

WFC Wells Fargo
$24.25 /

+0.07 (+0.29%)

UBER Uber
$34.70 /

+1.49 (+4.49%)

FB Facebook
$265.23 /

+16.045 (+6.44%)

AAL American Airlines
$13.04 /

+0.48 (+3.82%)

WFC Wells Fargo
$24.25 /

+0.07 (+0.29%)

UBER Uber
$34.70 /

+1.49 (+4.49%)

FB Facebook
$265.23 /

+16.045 (+6.44%)

AAL American Airlines
$13.04 /

+0.48 (+3.82%)

Hot Stocks
Pfizer announces agreement with Gilead to manufacture remdesivir » 08:05
08/07/20
08/07
08:05
08/07/20
08:05
PFE

Pfizer

$38.27 /

-0.18 (-0.47%)

, GILD

Gilead

$68.80 /

-0.19 (-0.28%)

Pfizer (PFE) said in a…

Pfizer (PFE) said in a release, "Pfizer announced a multi-year agreement with Gilead Sciences (GILD) to manufacture and supply Gilead's investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the terms of the agreement, Pfizer will provide contract manufacturing services at Pfizer's McPherson, Kansas facility to manufacture and supply remdesivir for Gilead. In March, Pfizer launched a five-point plan, which called on all members of the innovation ecosystem - from large pharmaceutical companies to the smallest of biotech companies, from government agencies to academic institutions - to commit to work together in addressing the dire COVID-19 crisis."

ShowHide Related Items >><<
PFE Pfizer
$38.27 /

-0.18 (-0.47%)

GILD Gilead
$68.80 /

-0.19 (-0.28%)

PFE Pfizer
$38.27 /

-0.18 (-0.47%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
GILD Gilead
$68.80 /

-0.19 (-0.28%)

08/03/20 Citi
Gilead price target raised to $80 from $78 at Citi
07/31/20 Wells Fargo
Gilead price target lowered to $76 from $87 at Wells Fargo
07/30/20 Piper Sandler
Gilead price target lowered to $85 from $90 at Piper Sandler
07/28/20 Piper Sandler
Piper Sandler lowers FY20, FY21 earnings forecasts for Gilead
PFE Pfizer
$38.27 /

-0.18 (-0.47%)

GILD Gilead
$68.80 /

-0.19 (-0.28%)

PFE Pfizer
$38.27 /

-0.18 (-0.47%)

GILD Gilead
$68.80 /

-0.19 (-0.28%)

PFE Pfizer
$38.27 /

-0.18 (-0.47%)

GILD Gilead
$68.80 /

-0.19 (-0.28%)

PFE Pfizer
$38.27 /

-0.18 (-0.47%)

GILD Gilead
$68.80 /

-0.19 (-0.28%)

Earnings
Circor reports Q2 adjusted EPS 22c, consensus 11c » 06:32
08/07/20
08/07
06:32
08/07/20
06:32
CIR

Circor

$30.07 /

-0.33 (-1.09%)

Reports Q2 revenue…

Reports Q2 revenue $186.1M, consensus $168.26M. "As we continue to navigate the COVID-19 environment, CIRCOR's top priority remains the health and safety of our employees, customers and suppliers," said CEO Scott Buckhout. "I would like to thank the entire CIRCOR team for doing a remarkable job serving our customers during this challenging time. I am pleased to report that as of today, all of our facilities are operational, with limited direct disruption from the COVID-19 pandemic. Our team has been effectively executing and building upon the 18-month strategic plan that we laid out last summer. Consistent with this plan, we completed our exit from upstream Oil & Gas, remain on track to launch 45 new products this year, and have expanded our planned 2020 cost actions to better align our cost structure with the current market environment. Looking ahead, we continue to focus on creating long-term value for shareholders by positioning the company for growth, expanding margins, generating strong free cash flow, and de-levering the balance sheet."

ShowHide Related Items >><<
CIR Circor
$30.07 /

-0.33 (-1.09%)

CIR Circor
$30.07 /

-0.33 (-1.09%)

05/31/20 Stifel
Stifel boosts Circor target to $32 from $17, adds to Select List
12/30/19 Stifel
Stifel sees Crane's acquisition of Circor business accretive in 2020
09/17/19
Fly Intel: Top five analyst upgrades
09/17/19
Circor upgraded to Overweight at KeyBanc
CIR Circor
$30.07 /

-0.33 (-1.09%)

CIR Circor
$30.07 /

-0.33 (-1.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.